---
title: "688363.SH (688363.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688363.SH/news.md"
symbol: "688363.SH"
name: "688363.SH"
parent: "https://longbridge.com/en/quote/688363.SH.md"
datetime: "2026-05-21T05:25:27.578Z"
locales:
  - [en](https://longbridge.com/en/quote/688363.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688363.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688363.SH/news.md)
---

# 688363.SH (688363.SH) — Related News

### [Bloomage Biotech: The controlling shareholder intends to fulfill the donation agreement in the near future, donating 1% of the company's shares free of charge](https://longbridge.com/en/news/285939161.md)
*2026-05-11T12:09:08.000Z*
> Bloomage Biotech's controlling shareholder, Huaxi Xinyu Investment Co., Ltd., plans to fulfill the donation agreement si

### [From Ingredients to Ecosystem: Runbaiyan's ECM Strategic Upgrade Sets a New Benchmark for Domestic Efficacy Skincare](https://longbridge.com/en/news/285465892.md)
*2026-05-07T01:27:20.000Z*
> Runbaiyan announced on April 29th the upgrade of its ECM strategy, launching the White Gauze Secondary Throw Essence 4.0

### [Tax Evasion "Standardized Process" Behind: The Era of Strong Regulatory Supervision in the Medical Aesthetics Industry Has Arrived](https://longbridge.com/en/news/285375221.md)
*2026-05-06T12:06:10.000Z*
> In recent years, tax authorities have strengthened their supervision of the medical beauty industry, severely cracking d

### [Bloomage Biotech's Rhodiola Rosea Extract has received FDA certification: Can synthetic biotechnology create another billion-dollar product category?](https://longbridge.com/en/news/285337613.md)
*2026-05-06T08:27:20.000Z*
> Bloomage Biotech Co., Ltd.'s Rhodiola Rosea Extract BLOOMSAS™ recently received Self-GRAS certification from the U.S. FD

### [Bloomage Biotech is trapped in a growth dilemma: revenue continues to decline, and profits relying on cost-cutting are not sustainable](https://longbridge.com/en/news/285066109.md)
*2026-05-04T11:35:02.000Z*
> Bloomage Biotech has continued to decline since its revenue peaked in 2022, with revenue dropping to 4.199 billion yuan 

### [From "Ingredient Skincare" to "Systematic Anti-Aging": The Industrial Logic and Biotech Breakthrough Behind Runbaiyan's ECM Strategy](https://longbridge.com/en/news/284751517.md)
*2026-04-30T10:57:20.000Z*
> Runbaiyan launched its ECM strategic upgrade in Beijing, introducing new products and fully upgrading its whitening prod

### [Bloomage Biotech and others established a new biotechnology company in Zhejiang](https://longbridge.com/en/news/284680108.md)
*2026-04-30T02:31:19.000Z*
> Bloomage Biotech's subsidiary, Beijing Bloomage Haiyu Technology Co., Ltd., has jointly established Sansen Wantu (Zhejia

### [Revenue and net profit attributable to shareholders both declined year-on-year! Bloomage Biotech's performance in the first quarter of this year faced a "late spring chill," why is it increasing investment in synthetic biology against the trend?](https://longbridge.com/en/news/284625716.md)
*2026-04-29T16:38:16.000Z*
> Bloomage Biotech (SH688363) released its Q1 2026 financial report, with operating revenue of 829 million yuan, a year-on

### [](https://longbridge.com/en/news/284549642.md)
*2026-04-29T10:44:44.000Z*
> Bloomage Biotech: Net profit for the first quarter was RMB 64.65 million, a year-on-year decrease of 36.55%

### [After the return of Zhao Yan, Chairman of Bloomage Biotech, "bone scraping therapy" was implemented, resulting in increased profits but no revenue growth last year](https://longbridge.com/en/news/284526807.md)
*2026-04-29T08:39:12.000Z*
> Bloomage Biotech's financial report for the fiscal year 2025 shows that although total revenue decreased by 21.82% year-